We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Domain Therapeutics Appoints Professor Michel Bouvier

News   Sep 23, 2014

 
Domain Therapeutics Appoints Professor Michel Bouvier
 
 
 

RELATED ARTICLES

Azafaros B.V. Secures Seed Funding to Develop New Treatments in Rare Metabolic Disorders

News

Company to address unmet medical needs in the field of rare metabolic disorders.

READ MORE

Chemistry Professor Awarded Prestigious Steenbock Professorship

News

University of Wisconsin–Madison Professor of Chemistry Shannon Stahl has received the Steenbock Professorship in Chemical Sciences. In addition to advancing the fundamental science in this area, Stahl has been involved in numerous industrial collaborations that have led to practical applications, including target applications relevant to pharmaceutical synthesis.

READ MORE

Molecular Key for Delaying Multiple Sclerosis Progression

News

In work just published it was possible to identify a receptor known as P2X4 present in the microglial cells that increases their anti-inflammatory potential in order to reduce the damage in Multiple Sclerosis and, above all, encourage the body's own repair responses.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE